Lynntech Inc.

Lynntech Inc., headquartered in College Station, Texas, is a for-profit small business that develops advanced science and engineering solutions for federal agencies, operating almost exclusively as a prime contractor across more than 930 awards spanning research, development, testing, and evaluation. The vendor competes predominantly under total small business set-asides, reflecting its consistent positioning in SBIR and STTR programs across the Department of Defense, civilian research agencies, and health-focused federal customers.

Lynntech's capability portfolio centers on applied and basic research and development across energy technologies (advanced batteries, hydrogen generation, fuel cells, supercapacitors), sensors and instrumentation (star trackers, optical systems, diagnostic platforms), medical devices (sterilization systems, wearable monitoring, wound-healing therapeutics), materials science (composites, coatings, additives manufacturing), and environmental solutions (wastewater treatment, water recovery systems). Representative work includes a $10.3 million Naval Air Warfare Center SBIR Phase III delivery order for RDT&E services under Topic N132-093 (awarded March 2026), a $6.5 million Air Force contract for joint multi-channel infusion pump technical maturation and risk reduction (April 2025), and a $5.97 million Air Force cost-plus-fixed-fee research contract for the Airman Readiness Medical Research program optimizing warfighter performance (May 2023). The vendor has also transitioned into Phase II and Phase III SBIR work; a $2.09 million Naval Air Warfare Center Phase II contract (February 2022) and a $1.8 million Air Force Phase II contract for HERMES hybrid-powered environmental surveillance (September 2023) exemplify scaling from feasibility studies into development and demonstration phases.

Customer concentration is heavily weighted toward Department of Defense research organizations and civilian research agencies. The top five customers account for 43 percent of combined potential value: Naval Air Warfare Center (44 awards, $40.4 million), Air Force Materiel Command Research Laboratory (78 awards, $36.1 million), Army Materiel Command Research Development and Engineering Command (69 awards, $32.1 million), Office of Naval Research (31 awards, $29.3 million), and Army Medical Command (38 awards, $19.8 million). By award count, the Air Force Materiel Command Research Laboratory leads with 78 awards, followed by Army RDECOM with 69; however, the Navy's consolidated spending across Naval Air Warfare Center and ONR anchors the largest dollar concentration. NASA (52 awards, $4 million) and National Institutes of Health (44 awards) round out active federal customers. Work is performed at Lynntech's College Station, Texas facility and at subordinate performance locations including Barksdale Air Force Base, Louisiana; Wright-Patterson Air Force Base, Ohio; and Aberdeen Proving Ground, Maryland, reflecting field testing and technical maturation requirements across defense and energy programs.

Lynntech holds a single-award Basic Ordering Agreement with Naval Air Warfare Center (N6833525G0017, awarded December 2024, ceiling through December 2029) for SBIR Phase III research, development, testing, and evaluation services. The BOA facilitates task-order procurement and demonstrates the Navy's reliance on Lynntech for transitioning mature SBIR concepts toward fieldable technologies. Beyond the BOA, Lynntech places task orders under numbered indefinite-delivery contracts including N0001412D0361 ($3.4 million combined potential value) and W911SR10D0018 ($25 thousand), indicating secondary positioning on Navy and Army research vehicles.

Activity has been consistent across the past five years—32 to 36 awards annually in 2022–2023, declining to 31 in 2024 and 24 in 2025, with 5 awards recorded in 2026 (through late September). This reflects the typical rhythm of SBIR Phase I solicitations (annual, high-volume, smaller award values ranging $150 thousand to $300 thousand) coupled with Phase II continuations (biennial or staggered, higher-ceiling awards in the $750 thousand to $2 million range). The recompete cliff is moderate: eighteen awards with ultimate completion dates within the next twenty-four months carry combined potential value of $20.5 million, representing straightforward recompete opportunities on SBIR Phase I topics and Phase II continuations already in Lynntech's pipeline.

SCI-reported invoicing shows Lynntech's federal services revenue at $4.3 million across FY2022–FY2025, with FTEs scaling from 2.8 (FY2022) to 4.6 (FY2025). Government-paid hourly rates on SCI contracts median around $115.87/hr, ranging from a 10th percentile of $104.44/hr to a 90th percentile of $230.73/hr, positioning Lynntech as a mid-tier technical labor provider on labor-hour contracts. Across SCI-reportable prime contracts, subcontractor hours account for only 1 percent of total hours, indicating that Lynntech self-performs substantially all delivery work. Lynntech has subcontracted minimally as a prime, with one named subcontractor reported in the SCI dataset and just two sub-award records in the broader contract portfolio (Mantech TSG-2 Joint Venture, May 2025; Accelint AI LLC, May 2023), making the vendor a self-sufficient technology developer rather than a prime that layers subcontractors.

Lynntech's federal grant footprint supplements its contract revenue. Recipients of federal grants from the National Institutes of Health, National Heart Lung and Blood Institute, and Centers for Disease Control and Prevention, Lynntech has received awards for diagnostic platform development (rapid SARS-CoV-2 RNA tests, Treponema pallidum point-of-care assays, Shiga toxin-producing E. coli irrigation-water testing), therapeutic development (COPD exacerbation early-warning systems, diabetic foot-ulcer wound-healing gels, broadly neutralizing antibodies for antiviral response), and biotechnology research (self-amplifying RNA optimization for vaccines and therapeutics). Grant work demonstrates capability in medical and health-science innovation complementary to its defense energy and sensor work.

The category concentration shows 236 of 933 awards classified under NAICS 541712 (Research and Development in Physical, Engineering, and Life Sciences) with primary PSC coding in space RDT&E, defense applied research, and basic research across national defense and civilian agencies. This reflects Lynntech's identity as a specialized SBIR performer optimized for phase-gated federal innovation programs rather than a broad-scope systems integrator or services contractor.

Lynntech scientists and engineers develop world-class technology solutions for aerospace, defense and human health. Our interdisciplinary approach and dedication to performance have driven innovation for more than 25 years.